President Trump yesterday left for a trip to the Far East. By the time he concludes the trip, it will be the longest trip by any US President since 1991. The president has vowed that he will take more stringent drug controls especially on opioid. However, this has not gone well with the Chinese government that has said it will not take part of the blame by the United States government that they have played a part in the opioid crisis in America. A few days ago, President Trump declared the opioid crisis in America as a public health emergency. It’s during the speech that the president said that he would deal with the cheap and the deadly fentanyl that was being flooded in America from China. However, the assertion that China also played a part in the problem was disputed by a Chinese official known as Wei Xiaojun. He further said that their argument had been based on a number of evidence and research that had been gathered from several countries. The evidence, therefore, didn’t point to the conclusion that all fentanyl originated from China. For starters, Mr. Wei is the deputy director of the narcotics control bureau. This is a body that is under the Ministry of Public Security.
However, in the Friday conference, the official said that he would not categorically deny that his country didn’t play a part in the opioid crisis. Mr. Trump has continued to insist that the drug either comes from China or it’s smuggled across the border by drug traffickers. The situation is a serious one as nearly 64,000 people died in the United States last year due to complications arising from drug overdoses. The same conclusion that China is to fault has been reached by a congressional commission. The commission known as US-China Economic and Security Review discovered that most of the fentanyl consumed in the United States, Canada and Mexico come from China. The commission said that the study had been carried out in February. The report further discovered that the Chinese authorities are not interested in controlling the drug’s export and production. The booming trade has further been fueled by the poor regulations in the chemicals industry. However, Beijing has resulted in the ban of nearly 23 variations of the product after pressure from the United States government. American Drug Enforcement Administration spokesman said that more needs to be done on the issue. However, China can do a lot considering its tough domestic laws on narcotics.